FindTrial
Sign In

Evaluation of salivary biomarkers for early detection of oral cancer and precancerous conditions

Evaluation of salivary gamma synuclein, IL-6 and IL-8 in patients with oral malignancies and potentially malignant oral disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046302
Enrollment
60
Registered
2022-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Vinayalekshmy I N Nair
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Oral malignancies Potentially malignant oral disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of salivary gamma synuclein, IL-6, IL-8Timepoint: Before treatment—

Secondary

MeasureTime frame
Levels of IL-6, levels of IL-8Timepoint: Before treatment—

Countries

India

Contacts

Public ContactVinayalekshmy I N Nair

Banaras Hindu University

adit@bhu.ac.in9451525522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026